We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$466M
AUM Growth
+$23.6M
(+5.3%)
Cap. Flow
-$35.1M
Cap. Flow
% of AUM
-7.54%
Top 10 Holdings %
Top 10 Hldgs %
39.12%
Holding
698
New
128
Increased
157
Reduced
205
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.93M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$7.4M |
| 3 |
Stellantis
STLA
|
+$6.45M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$6.05M |
| 5 |
WIX.com
WIX
|
+$4.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$15M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$11.5M |
| 3 |
Vale
VALE
|
+$9.09M |
| 4 |
United States Oil Fund
USO
|
+$7.39M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.82% |
| 2 | Consumer Discretionary | 7.26% |
| 3 | Technology | 6.74% |
| 4 | Consumer Staples | 5.01% |
| 5 | Materials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
iShares MBS ETF
MBB
$39.1B
| $4.16K | ﹤0.01% |
39
| – | – |
|
427
Boston Scientific
BSX
$68.4B
| $4.16K | ﹤0.01% |
150
-1,538
| -91% | -$40.8K |
|
|
CCP
428
DELISTED
Care Capital Properties, Inc.
CCP
| $3.76K | ﹤0.01% |
141
| – | – |
|
429
PUT
Blackstone
BX
$104B
| $3.6K | ﹤0.01% |
400
| – | – |
|
430
Omnicom Group
OMC
$22.7B
| $2.9K | ﹤0.01% |
35
-5
| -13% | -$417 |
|
431
CALL
Qiagen
QGEN
$8.62B
| $2.84K | ﹤0.01% |
+349
| New | +$11.8K |
|
432
iShares MSCI Germany ETF
EWG
$1.56B
| $2.63K | ﹤0.01% |
87
-531
| -86% | -$16K |
|
433
CALL
Diageo
DEO
$49.6B
| $2.56K | ﹤0.01% |
6
-243
| -98% | -$28.9K |
|
|
434
PUT
Diageo
DEO
$49.6B
| $2.56K | ﹤0.01% |
70
-40
| -36% | -$4.76K |
|
435
Yum! Brands
YUM
$41.9B
| $2.43K | ﹤0.01% |
33
-19
| -37% | -$1.32K |
|
436
NVR
NVR
$17.1B
| $2.41K | ﹤0.01% |
1
| – | – |
|
437
Royal Gold
RGLD
$16.6B
| $2.35K | ﹤0.01% |
+30
| New | +$2.26K |
|
|
RDS.A
438
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.2K | ﹤0.01% |
+160
| New | +$8.57K |
|
|
RDS.A
439
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.2K | ﹤0.01% |
+40
| New | +$2.14K |
|
|
RDUS
440
DELISTED
Radius Health, Inc.
RDUS
| $2.17K | ﹤0.01% |
+48
| New | +$1.83K |
|
441
Booking.com
BKNG
$156B
| $1.87K | ﹤0.01% |
+25
| New | +$1.83K |
|
442
Genuine Parts
GPC
$17.9B
| $1.85K | ﹤0.01% |
20
-11
| -35% | -$1.01K |
|
|
WBA
443
DELISTED
Walgreens Boots Alliance
WBA
| $1.8K | ﹤0.01% |
23
-14
| -38% | -$1.15K |
|
444
Northrop Grumman
NOC
$76B
| $1.8K | ﹤0.01% |
7
-39
| -85% | -$9.76K |
|
445
Quest Diagnostics
DGX
$26B
| $1.78K | ﹤0.01% |
+16
| New | +$1.69K |
|
446
CALL
TotalEnergies
TTE
$193B
| $1.77K | ﹤0.01% |
+40
| New | +$2.06K |
|
447
Costco
COST
$432B
| $1.76K | ﹤0.01% |
11
+4
| +57% | +$689 |
|
448
Baidu
BIDU
$35.7B
| $1.61K | ﹤0.01% |
9
| – | – |
|
449
Ambarella
AMBA
$3.04B
| $1.6K | ﹤0.01% |
33
| – | – |
|
450
TJX Companies
TJX
$179B
| $1.59K | ﹤0.01% |
44
-70,316
| -100% | -$2.65M |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2017 Portfolio in Review
As of Q2 2017, Exane Derivatives held 698 positions worth $466M, up 5.3% from $442M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Exane Derivatives withdrew a net $35.1M in Q2 2017, closing 67 positions and reducing 205 holdings. Its most notable exit was Deutsche Bank Aktiengesellschaft, an estimated $6.91M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $8.27M.
- Exane Derivatives's largest Q2 2017 buy was UBS Group: 487,870 shares worth $8.27M.
- Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $7.4M increase.
- Exane Derivatives's biggest Q2 2017 reduction was VanEck Russia ETF, cutting an estimated $15M.
- Exane Derivatives fully exited Deutsche Bank Aktiengesellschaft in Q2 2017, selling an estimated $6.91M.
- Exane Derivatives's ten largest holdings make up 39% of its $466M portfolio in Q2 2017.
- Exane Derivatives opened 128 new positions and closed 67 in Q2 2017.
- Exane Derivatives's portfolio value rose 5.3% quarter-over-quarter to $466M.
Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.